SCHEMBL5680435

SCHEMBL5680435

[CH2]CCCC1CCC(CO)CC1

nearest known ligand 0.34

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
ESR1 P03372 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
ESR2 Q92731 1/20 0.33
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9750 0.87
SCHEMBL5678819 0.84 ESR1 (0.35) ESR1CYP3A4CYP2C9ESR2
SCHEMBL4809683 0.80 LMNA (0.34) LMNAMAPK1HTTCYP1A2
SCHEMBL1111263 0.79 ESR2 (0.35) LMNAMAPK1HTTESR1CYP3A4
SCHEMBL128219 0.78
SCHEMBL9815717 0.78 ESR2 (0.41) ESR1CYP3A4CYP2C9ESR2
SCHEMBL5680336 0.78 CYP1A2 (0.31) ESR1CYP3A4CYP2C9ESR2CYP1A2
SCHEMBL11674003 0.77 SIGMAR1 (0.34) LMNAMAPK1HTTESR1CYP3A4
SCHEMBL3390757 0.76 SIGMAR1 (0.42) LMNAMAPK1HTTCYP1A2
SCHEMBL866489 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107406547-B Polymer particles, method for producing polymer particles, and use thereof 积水化成品工业株式会社 2019-10-15 CN disclosed
CN-107406547-A Polymer particles, method for producing polymer particles, and use thereof 积水化成品工业株式会社 2017-11-28 CN disclosed
EP-1184396-B1 (Meth)acrylate ester-based resin composition NIPPON CATALYTIC CHEM IND (JP) 2006-02-01 EP disclosed
US-6686413-B2 AQUEOUS DISPERSON OF A POLYMER CONTAINING UNITS OF A CYCLOHEXYLALKYL ESTER OF (METH)ACRYLIC ACID NIPPON SHOKUBAI CO., LTD. (JP) 2004-02-03 US disclosed
US-6489396-B2 A CYCLOHEXYL CONTAINING (METH)ACRYLIC ESTER-BASED POLYMER CROSSLINKED WITH A DI-FUNCTIONAL CROSSLINKING AGENT; LOW VISCOSITY RESIN FOR LOW VOLATILE ORGANIC COMPOUND (VOC)-PAINTS NIPPON SHOKUBAI CO., LTD. (JP) 2002-12-03 US disclosed
US-20020091197-A1 (Meth)acrylate ester-based resin composition NIPPON SHOKUBAI CO., LTD. (JP) 2002-07-11 US disclosed
EP-1205498-A1 (Meth)acrylate ester-based resin composition Nippon Shokubai Co., Ltd. (JP) 2002-05-15 EP disclosed
US-20020045702-A1 (Meth)acrylate ester-based resin composition NIPPON SHOKUBAI CO., LTD. (JP) 2002-04-18 US disclosed
EP-1184396-A1 (Meth)acrylate ester-based resin composition Nippon Shokubai Co., Ltd. (JP) 2002-03-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020045702-A1 (Meth)acrylate ester-based resin composition MNAT1, MAT1A, COPE LMNA 1220/4885MAPK1 1086/4885HTT 244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.